Press Releases

Titan Medical Announces Successful Completion of Human Factors Evaluation for its Single-Port Robotic Surgical System, Provides Development and Regulatory Update

TORONTO (August 26, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that the human factors evaluation (“HFE”) required to support its planned Investigational Device Exemption (“IDE”) […]

Titan Medical Announces Successful Completion of Survival Phase of GLP Chronic Procedures with its Single-Port Robotic Surgical System

TORONTO (August 6, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces the successful completion of the chronic procedures performed under Good Laboratory Practice (“GLP”) principles using […]

Titan Medical Reports Second Quarter 2019 Financial Results

TORONTO (July 31, 2019) – Titan Medical Inc. (TSX: TMD) (NASDAQ: TMDI) (“Titan” or “the Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces financial results for the three and six months ended June 30, 2019. All financial results are […]

Letter to Shareholders

Dear Titan Medical Shareholders, It is my pleasure to provide this mid-year update on Titan Medical’s progress and to share with you our outlook for the remainder of the year. The first half of 2019 has been very busy and productive. Our dedicated management team, consultants and product development partners have been relentlessly executing on […]

Titan Medical Completes Preclinical Good Laboratory Practice Procedures with its Single-Port Robotic Surgical System

TORONTO (July 18, 2019) – Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that all procedures under Good Laboratory Practice (“GLP”) principles associated with the acute and chronic […]